Logo image
Sign in
Cost-effectiveness of Pegfilgrastim versus Filgrastim after high-dose chemotherapy and autologous stem cell transplantation in patients with lymphoma and myeloma
Journal article   Peer reviewed

Cost-effectiveness of Pegfilgrastim versus Filgrastim after high-dose chemotherapy and autologous stem cell transplantation in patients with lymphoma and myeloma

Lionel Perrier, Anne Lefranc, Philippe Quittet, Philippe Moreau, Carole Siani, Hervé Ghesquières, Fabrice Jardin, Bertrand Favier, Norbert Ifrah, Séverine Lissandre, …
Applied Health Economics and Health Policy, Vol.11(2), pp.pp. 129-138
2013

Abstract

Cost-effectiveness Pegfilgrastim Filgrastim I - Health, Education, and Welfare/I.I1 - Health I - Health, Education, and Welfare/I.I1 - Health/I.I1.I11 - Analysis of Health Care Markets I - Health, Education, and Welfare/I.I1 - Health/I.I1.I18 - Government Policy • Regulation • Public Health
url
Find in HALView

Metrics

1 Record Views

Details

Logo image